Skip to main content

Healthcare professional experiences and attitudes on unlicensed/off-label paediatric prescribing and paediatric clinical trials

Abstract

Objectives

To investigate the knowledge and views of a range of healthcare professionals (consultant paediatricians, general practitioners (GPs), community pharmacists and paediatric nurses) regarding the use of unlicensed/off-label medicines in children and the participation of children in clinical trials.

Methods

A regional study in which a survey instrument with 39 items was issued to 500 randomly selected GPs, all community pharmacists (n = 512), 50 hospital consultants and 150 paediatric nurses in Northern Ireland.

Results

Approximately half (46.5%) of the 1,212 healthcare professionals approached responded to the questionnaire. The majority of respondents indicated their familiarity with the term unlicensed (82.9%) or off-label (58.6%) prescribing with the most frequently quoted reason for such prescribing being younger age (33.6%). Apart from community pharmacists, most respondents reported having gained their knowledge through personal experience. Even though a large percentage of respondents expressed concerns about the safety (77.8%) or efficacy (87.9%) of unlicensed/off-label prescribing in children, only 30.7% reported informing parents/guardians of these concerns on the use of such medicines in children. In addition, only 56% of respondents believed that unlicensed/off-label medicines should undergo clinical trials in children. Overall, 28.4% of respondents (20.1% of GPs, 41.4% of community pharmacists, 27.7% of paediatric nurses and 94% of consultant paediatricians) indicated their willingness to be actively involved in, and recruit their patients for paediatric clinical research.

Conclusion

The use of unlicensed and off-label medicines remains a major issue in paediatric medicine. Until such times as more licensed medicines are available for children, clear guidance should be developed to allow consistency in practice across the spectrum of healthcare professionals who are involved with such medicines in their routine practice.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3

References

  1. De Wildt SA, Johnson TN, Choonara I (2003) The effect of age on drug metabolism. Paediatr Perinat Drug Ther 5:101–106

    Article  Google Scholar 

  2. Sammons HM. Ethical considerations for clinical trials on medicinal products conducted in the paediatric population. Recommendations of the ad hoc group for the development of implementing guidelines for Directive 2001/20/EC relating to good clinical practice in the conduct of clinical trials on medicinal products for human use. Available at: https://ec.europa.eu/health/files/eudralex/vol-10/ethical_considerations_en.pdf. Accessed 7 Dec 2010

  3. Budetti PP (2003) Ensuring safe and effective medications for children. JAMA 290:950–951

    PubMed  Article  Google Scholar 

  4. Steinbrook R (2002) Testing medications in children. N Engl J Med 347:1462–1470

    PubMed  Article  Google Scholar 

  5. Collier J (1999) Paediatric prescribing: using unlicensed drugs and medicines outside their licensed indications. J Clin Pharmacol 48:5–8

    CAS  Google Scholar 

  6. Pandolfini C, Bonati M (2005) A literature review on off-label drug use in children. Eur J Pediatr 164:552–558

    PubMed  Article  Google Scholar 

  7. Ekins-Daukes S, Taylor M, Helms PJ, McLay JS (2005) Off label prescribing to children: attitudes and experience of general practitioners. Br J Clin Pharmacol 60:145–149

    PubMed  Article  Google Scholar 

  8. Chalumeau M, Tréluyer JM, Salanave B et al (2000) Off label and unlicensed drug use among French office based paediatricians. Arch Dis Child 83:502–505

    PubMed  Article  CAS  Google Scholar 

  9. Marchetti F, Bua J, Ventura A, Notarangelo LD, Di Maio S, Migliore G, Bonati M (2007) The awareness among paediatricians of off-label prescribing in children: a survey of Italian hospitals. Eur J Clin Pharmacol 63:81–85

    PubMed  Article  Google Scholar 

  10. Hoppu K (2008) Paediatric clinical pharmacology: at the beginning of a new era. Eur J Clin Pharmacol 64:201–205

    PubMed  Article  Google Scholar 

  11. Impicciatore P, Choonaara I, Clarkson A, Provasi D, Pandolfini C, Bonati M (2002) Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Lancet 359:1373–1378

    Article  Google Scholar 

  12. Choonara I, Conroy S (2002) Unlicensed and off label drug use in children: implications for safety. Drug Saf 25:1–5

    PubMed  Article  Google Scholar 

  13. Turner S, Nunn AJ, Fielding K, Choonara I (1999) Adverse drug reactions to unlicensed and off label drugs on paediatric wards: a prospective study. Acta Paediatr 88:965–968

    PubMed  Article  CAS  Google Scholar 

  14. Sammons H (2009) Ethical issues of clinical trials in children: a European perspective. Arch Dis Child 94:474–477

    PubMed  Article  CAS  Google Scholar 

  15. Stewart D, Rouf A, Snaith A et al (2007) Attitudes and experiences of community pharmacists towards paediatric off-label prescribing: a prospective survey. Br J Clin Pharmacol 64:90–95

    PubMed  Article  Google Scholar 

  16. Turner S, Longworth A, Nunn A et al (1998) Unlicensed and off label drug use in paediatric wards: prospective study. Br Med J 316:343–345

    CAS  Google Scholar 

  17. Ekins-Daukes S, Simpson C, Helms PJ et al (2004) Paediatric off label prescribing in general practice. Eur J Clin Pharmacol 60:349–353

    PubMed  Article  Google Scholar 

  18. Lenk C, Koch P, Zappel H, Wiesemann C (2009) Off-label, off-limits? Parental awareness and attitudes towards off-label use in paediatrics. Eur J Pediatr 168:1473–1478

    PubMed  Article  Google Scholar 

  19. Mukattash TL, Millership JS, Collier PS, McElnay JC (2008) Public awareness and views on unlicensed use of medicines in children. Br J Clin Pharmacol 66(6):838–845

    PubMed  Article  CAS  Google Scholar 

  20. Fortescue EB, Kaushal R, Landrigan PC et al (2003) Prioritizing strategies for preventing medication errors and adverse drug events in pediatric inpatients. Pediatrics 111:722–729

    PubMed  Article  Google Scholar 

  21. McLay JS, Tanaka M, Ekins-Daukes S, Helms PJ (2006) A prospective questionnaire assessment of attitudes and experiences of off label prescribing among hospital based paediatricians. Arch Dis Child 91:584–587

    PubMed  Article  CAS  Google Scholar 

Download references

Conflict of interests

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to James C. McElnay.

Appendix 1: The use of unlicensed and off-label medicines in children

Appendix 1: The use of unlicensed and off-label medicines in children

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Mukattash, T., Hawwa, A.F., Trew, K. et al. Healthcare professional experiences and attitudes on unlicensed/off-label paediatric prescribing and paediatric clinical trials. Eur J Clin Pharmacol 67, 449–461 (2011). https://doi.org/10.1007/s00228-010-0978-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-010-0978-z

Keywords

  • Unlicensed medicines
  • Off-label medicines
  • Clinical trials
  • Children